Alaska Permanent Fund’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,624	Closed	-$2.77M	–	353
2025 Q1	$2.77M	Hold	4,624	–	–	0.04%	201
2024 Q4	$3.29M	Hold	4,624	–	–	0.05%	172
2024 Q3	$4.86M	Hold	4,624	–	–	0.07%	113
2024 Q2	$4.99M	Buy	4,624 +720	+18%	+$698K	0.07%	114
2024 Q1	$3.76M	Buy	3,904 +58	+2%	+$55.2K	0.06%	130
2023 Q4	$3.38M	Buy	3,846 +1,641	+74%	+$1.35M	0.06%	128
2023 Q3	$1.81M	Buy	2,205 +1,720	+355%	+$1.35M	0.03%	312
2023 Q2	$348K	Buy	+485	New	+$374K	0.01%	361
2022 Q4	$267K	Buy	370 +2	+0.5%	+$1.48K	﹤0.01%	325
2022 Q3	$253K	Buy	368 +58	+19%	+$36.5K	﹤0.01%	319
2022 Q2	$183K	Sell	310 -4,838	-94%	-$3.14M	﹤0.01%	322
2022 Q1	$3.6M	Sell	5,148 -18	-0.3%	-$11.4K	0.06%	44
2021 Q4	$3.14M	Buy	5,166 +166	+3%	+$102K	0.06%	43
2021 Q3	$3.03M	Hold	5,000	–	–	0.06%	46
2021 Q2	$2.79M	Buy	+5,000	New	+$2.53M	0.05%	37